STUB1 and neoplasm: The 46 primary tumor regions from 21 patients with CHIP had a higher representation of myeloid cells compared to the 117 tumor regions from 49 patients without CHIP (Fig 1D and Fig S6; age-adjusted odds ratio [OR]=1.20, 95% CI 1.01-1.43).